Adaptive responses of the HER2+ SKBR-3 and BT474m1 cell lines to lapatinib and JQ1. Adaptive responses of the HER2+ SKBR-3 and BT474m1 cell lines to lapatinib and JQ1

NIAID Data Ecosystem2026-03-12 收录

HER2阳性乳腺癌药物应答

抗癌药物适应性反应

数据链接：

https://www.ncbi.nlm.nih.gov/bioproject/PRJNA671649 数据链接链接失效反馈

官方服务：

资源简介：

SKBR-3 or BT474m1 HER2+ breast cancer cells were treated with either DMSO, 300nM lapatinib, 300nM JQ1, or lapatinib and JQ1 in combination for 48h. Overall design: 8 experimental samples

创建时间：

2020-10-25

Adaptive responses of the HER2+ SKBR-3 and BT474m1 cell lines to lapatinib and JQ1. Adaptive responses of the HER2+ SKBR-3 and BT474m1 cell lines to lapatinib and JQ1

资源简介：

相关数据集